These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
127 related items for PubMed ID: 11365406
1. Hepatitis C important treatment advance: interview with Douglas Dieterich, M.D. Interview by John S. James. Dieterich D. AIDS Treat News; 1998 May 15; (No 295):1-5. PubMed ID: 11365406 [Abstract] [Full Text] [Related]
2. Hepatitis C: new treatment overview. Stoia J. AIDS Treat News; 1998 Sep 04; (302):5-6. PubMed ID: 11365763 [Abstract] [Full Text] [Related]
3. Hepatitis C and HIV: ribavirin plus interferon study recruiting. AIDS Treat News; 1998 May 15; (No 295):5. PubMed ID: 11365407 [Abstract] [Full Text] [Related]
4. Treating hepatitis C: a clinician's perspective. Interview by Bob Roehr. Powell J. J Int Assoc Physicians AIDS Care; 1998 Jul 15; 4(7):31-5. PubMed ID: 11365640 [Abstract] [Full Text] [Related]
5. Ribavirin approved with a big fat price. Falkenberg J. Notes Undergr; 1998 Jul 15; (No 37):10-1. PubMed ID: 11365818 [Abstract] [Full Text] [Related]
6. Alpha-interferon with ribavirin in the treatment of hemodialysis patients with hepatitis C. Mousa DH, Abdalla AH, Al-Shoail G, Al-Sulaiman MH, Al-Hawas FA, Al-Khader AA. Transplant Proc; 2004 Jul 15; 36(6):1831-4. PubMed ID: 15350490 [Abstract] [Full Text] [Related]
8. Hepatitis C virus-RNA clearance in HIV-coinfected patients with chronic hepatitis C treated with pegylated interferon plus ribavirin. Soriano V, Núñez M, Camino N, Maida I, Barreiro P, Romero M, Martin-Carbonero L, Garcia-Samaniego J, González-Lahoz J. Antivir Ther; 2004 Aug 15; 9(4):505-9. PubMed ID: 15456081 [Abstract] [Full Text] [Related]
10. Anemia during treatment of hepatitis C in HIV-infected patients. Lo Re V, Kostman JR. AIDS Read; 2004 Oct 15; 14(10):555-7, 562, 565-71. PubMed ID: 15510392 [Abstract] [Full Text] [Related]
11. Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups. Schaefer M, Schmidt F, Folwaczny C, Lorenz R, Martin G, Schindlbeck N, Heldwein W, Soyka M, Grunze H, Koenig A, Loeschke K. Hepatology; 2003 Feb 15; 37(2):443-51. PubMed ID: 12540795 [Abstract] [Full Text] [Related]
12. High-dose interferon-alpha 2b plus ribavirin combination therapy for GB virus-C/hepatitis G virus infection--a study in patients with chronic hepatitis C. Cheng PN, Jen CM, Young KC, Chen CY, Lu SN, Wang CS, Chang TT. Hepatogastroenterology; 2003 Feb 15; 50(50):449-52. PubMed ID: 12749244 [Abstract] [Full Text] [Related]
14. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C. Abdelmalek MF, Firpi RJ, Soldevila-Pico C, Reed AI, Hemming AW, Liu C, Crawford JM, Davis GL, Nelson DR. Liver Transpl; 2004 Feb 15; 10(2):199-207. PubMed ID: 14762857 [Abstract] [Full Text] [Related]
15. Treatment of hepatitis C virus/HIV coinfection. Chun S, Sherman KE. Clin Liver Dis; 2005 Aug 15; 9(3):525-33, ix. PubMed ID: 16023981 [Abstract] [Full Text] [Related]
17. Double trouble: coinfection with HIV and hepatitis C. Bundow D, Turin C. STEP Perspect; 1999 Dec 15; 99(1):16-7, 20. PubMed ID: 11367157 [Abstract] [Full Text] [Related]